Market Overview:
The artificial intelligence in digital genome market focuses on integrating genomic data with artificial intelligence algorithms. This allows comprehensive analysis of genetic information to help diagnose and treat diseases. Key applications include precision medicine, genetic screening, drug discovery, and agricultural genetics. Advancements in DNA sequencing technologies have enabled decoding of complete human genomes faster and cheaper. This has increased the adoption of AI-powered tools for analyzing huge genomic data to derive clinical insights.
Market Dynamics:
The growth of the artificial intelligence in digital genome market is majorly driven by advancements in genomic technologies that have led to exponential rise in availability of genomic data. For instance, next-generation sequencing technologies can generate terabytes of genomic data in a single run. Analyzing such vast amounts of unstructured genomic data manually is nearly impossible. This is boosting the adoption of AI-based platforms that can autonomously detect patterns, predict outcomes, and provide clinically relevant interpretations from genomic profiles.
Another key driver is increasing adoption of precision medicine approaches for diagnosing and treating diseases based on a person's genes, lifestyle and environment. AI assists in personalized treatment planning by connecting a person's medical records, genomic variations, and clinical outcomes. This is expected to significantly aid healthcare providers in delivering targeted therapeutics.
The global Artificial Intelligence In Digital Genome Market Share is estimated to be valued at US$ 565.69 Mn in 2023 and is expected to exhibit a CAGR of 44.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: The artificial intelligence in digital genome market benefits from high technological advancements in the field of genome sequencing. AI helps analyze huge amounts of complex sequencing data rapidly. AI tools also help discover new insights from genomics data.
Weakness: Limited computational power and data availability pose challenges for AI in analyzing genomes. Lack of expertise and high investment requirements also limit the growth of artificial intelligence in digital genome market.
Opportunity: Growing application of AI in precision medicine and drug discovery creates new revenue streams for market players. Integration of AI with other technologies such as cloud and IoT further enhances its potential.
Threats: Data privacy and security concerns restrict genomic data sharing. Lack of regulations for clinical use of AI-based genomic technologies increases investment risk.
Key Takeaways:
The global Artificial Intelligence In Digital Genome Market is expected to witness high growth, exhibiting CAGR of 44% over the forecast period, due to increasing investments from pharmaceutical and biotechnology companies in computational genomics. Various partnerships between AI and genomics companies are further fueling the market growth.
Regional analysis: North America dominated the global market in 2023, owing to strong government funding for genomics research and presence of key market players in the US. However, Asia Pacific is projected to witness the highest growth during the forecast period driven by rising healthcare expenditures, increasing genomics research in China and India.
Key players operating in the Artificial Intelligence In Digital Genome Market are NVIDIA Corporation, IBM, Microsoft, Fabric Genomics Inc., Verge Genomics, MolecularMatch Inc., SOPHiA GENETICS, PrecisionLife Ltd, BenevolentAI, and Deep Genomics. Key players are focusing on new product launches, partnerships and mergers & acquisitions to strengthen their market position.
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian